Worksport Q3 Sales Up 44% to $7.2M, but Going Concern and Material Weakness Persist
WKSP sits 28% above its 52-week low of $0.26 on light trading volume (0.1× avg).
Summary
Worksport grew Q3 sales 44% to $7.2M and narrowed its quarterly loss, but cash is down to $2.5M, going-concern doubt and a material weakness remain, and the company keeps funding itself by issuing stock and warrants.
Key Events · Earnings and Guidance · WKSP
-
Q3 Sales Jump 44% to $7.2M
Net sales were $7,228,298 versus $5,013,872 a year earlier, with gross profit of $2,188,707 (30% margin) against $1,568,784.
-
Quarterly Loss Narrows to $3.6M
Net loss was $3,599,392, or $0.26 per share, versus $4,928,679, or $0.75 per share, in Q3 2025; the nine-month loss was $13,393,217 versus $13,123,627.
-
Cash Falls to $2.5M, Going Concern Reiterated
Cash and equivalents dropped to $2,528,222 from $5,945,894 at December 31, 2025, with $1,818,887 left on the revolver and an accumulated deficit of $97,348,858; the filing states substantial doubt about continuing as a going concern.
-
Material Weakness in Controls Persists
Management concluded disclosure controls were not effective due to a material weakness tied to insufficient written policies, inadequate documentation and segregation-of-duties gaps; remediation is ongoing.
Analysis · WKSP · Manufacturing
The revenue growth is real: net sales rose 44.2% to $7,228,298, and the quarterly net loss narrowed to $3,599,392 from $4,928,679. Yet cash fell to $2,528,222 from $5,945,894 at year-end, the company again states substantial doubt about its ability to continue as a going concern, and management concluded disclosure controls were not effective because of a material weakness. Stock sales funded much of the quarter: 4,006,728 ATM shares for $4,496,875 gross, plus an August warrant inducement that brought in $2,304,253 while issuing 4,800,526 new warrants at $0.60. After the quarter, the board approved an option exchange and granted 2,200,000 options to CEO Steven Rossi plus 50,000 each to four directors, and set transaction bonuses of 10% of subsidiary-sale consideration for Rossi and a 4% pool for a strategic deal. The Nasdaq $1.00 bid deficiency, with a February 9, 2027 cure deadline, remains unresolved.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WKSP was trading at $0.33 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.8M. The 52-week trading range was $0.26 to $3.13. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.